Found 28 matching trials
ALK21-018: Effects of MedisorbĀ® Naltrexone (VIVITROLĀ®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults
PHASE4This was a study of the effects of VIVITROLĀ® on alcohol cue-induced craving...
ALK21-021: A Safety Study of MedisorbĀ® Naltrexone (VIVITROLĀ®) Administered to Health Care Professionals
PHASE3The purpose of this study is to determine the safety and tolerability of Me...
Location
Alkermes Clinical Study Site
Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)
PHASE2This is an 8-week, double-blind, randomized placebo-controlled trial of the...
Location
University of Alabama at Birmingham
Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults
PHASE4This study seeks to compare the effectiveness of two medications used to tr...
Location
Yale University School of Medicine
Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone
PHASE2To address the question of the comparison of two courses of Vivitrol with d...
Location
Federal Medical Research Center for Psychiatry and Narcology (FMRC)
A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.
PHASE1A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerabilit...
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
PHASE1Specific Aim: To conduct a randomized, placebo-controlled trial of extended...
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
PHASE1Naltrexone (NTX), an opioid receptor antagonist, has a longstanding history...
ALK21-003: Study of MedisorbĀ® Naltrexone (VIVITROLĀ®) in Alcohol-Dependent Adults
PHASE3This was a Phase 3, multicenter, randomized, double-blind, placebo-controll...
Location
Multiple Locations
Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care
PHASE4The proposed study is a pragmatic, randomized, open-label clinical trial of...
Location
New York University School of Medicine